Early Stage Non-small Cell Lung Cancer

Oncology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Varian Medical Systems
1 program
Computed tomography-guided stereotactic adaptive radiotherapyN/A1 trial
Active Trials
NCT05785845Active Not RecruitingEst. Jul 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Varian Medical SystemsComputed tomography-guided stereotactic adaptive radiotherapy

Clinical Trials (1)

NCT05785845Varian Medical SystemsComputed tomography-guided stereotactic adaptive radiotherapy

Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer

Start: Apr 2023Est. completion: Jul 2026
N/AActive Not Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space